Contracting retail pharmacies as a source of essential medicines for public sector clients in low- and middle-income countries: a scoping review of key considerations, challenges, and opportunities

• Published in: Journal of pharmaceutical policy and practice 2023-05, Vol.16 (1), p.60-60
• Main Authors: Kaplan, Warren A, Cellini, Carlotta M, Eghan, Kwesi, Pilz, Kevin, Harrison, Denise, Wirtz, Veronika J
• Format: Article
• Language: English
• Subjects: Access; Agreements; Case studies; Consulting services; Contract manufacturing; Contracts; Cost control; COVID-19; Drug stores; Drugs; Drugstores; Essential medicines; Health; Health system administration; Health system strengthening; Human resources; Hypertension; Income; Industrialized nations; Industry sales and revenue; Logistics; Low- and middle-income countries; Medical care; Medicine; National health insurance; Pandemics; Partnerships; Patients; Pharmaceuticals; Pharmacy; Primary care; Private sector; Public finance; Public sector; Public–private contracting; Quality management; Quality of care; Reimbursement; Retail pharmacies; Review
• ISSN: 2052-3211; 2052-3211
• DOI: 10.1186/s40545-023-00557-w

Insurances in high-income countries (HIC) often contract with private community pharmacies to dispense medicines to outpatients. In contrast, dispensing of medicines in low- and middle-income countries (LMICs) often lacks such contractual arrangements. Furthermore, many LMICs lack sufficient investment in supply chains and financial and human resources to guarantee stock levels and services at public medicine-dispensing institutions. Countries striving to achieve universal health coverage (UHC) can, in principle, incorporate retail pharmacies into their supply chains to expand access to essential medicines (EMs). The objectives of this paper are (a) to identify and analyze key considerations, opportunities and challenges for public payers when contracting out the supply and dispensing of medicines to retail pharmacies and (b) to provide examples of strategies and policies to address these challenges. A targeted literature strategy was used to conduct this scoping review. We created an analytical framework of key dimensions: (1) governance (including medicine and pharmacy regulation); (2) contracting (3) reimbursement; (4) medicine affordability (5) equitable access; and (6) quality of care (including 'patient-centered' pharmaceutical care). Using this framework, we selected a mix of three HIC and four LMIC case studies and analyzed the opportunities and challenges encountered when contracting retail pharmacies. From this analysis, we identified a set of opportunities and challenges that should be considered by public payers considering public-private contracting: (1) balancing business viability with medicine affordability; (2) incentivizing equitable access to medicines; (3) ensuring quality of care and delivery of services; (4) ensuring product quality; (5) task-sharing from primary care providers to pharmacies and (6) securing human resources and related capacity constraints to ensure sustainability of the contract. Public-private partnerships offer opportunities to improve access to EMs. Nonetheless, managing these agreements is complex and is influenced by a variety of factors. For effective contractual partnerships, a systems approach is needed in which business, industry and regulatory contexts are considered in tandem with the health system. Special attention should be devoted to rapidly changing health contexts and systems, such as changes in patient preferences and market developments brought about by the COVID-19 pandemic.